Related Experiment Videos
Human platelet calcium mobilisation in response to beta-amyloid (25-35): buffer dependency and unchanged response in
H L Hedin1, S Eriksson, C J Fowler
1Department of Pharmacology and Clinical Neuroscience, Umeå University, SE-901 87, Umeå, Sweden. henrietta.hedin@pharm.umu.se
Abstract:
In the present study, the effects of beta-amyloid (25-35) (Abeta (25-35)) upon calcium signalling by the human platelet has been investigated. When assays were conducted using HEPES buffers, Abeta (25-35), but not the inactive peptide Abeta (35-25), produced a robust increase in intracellular calcium that remained after removal of extracellular calcium but was abolished by the phospholipase C inhibitor U-73122. There was no significant difference between the calcium response to Abeta (25-35) in platelets from patients with Alzheimer's disease and from age-matched controls. In contrast to the robust effects on calcium mobilisation in HEPES buffers, very little calcium response to Abeta (25-35) was seen when Krebs (pH 7.8) buffer was used.